News

Business Insider5d
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Further presentations covered the antifungal isavuconazole (Cresemba ®) and the antibiotic ceftobiprole (Zevtera ®). Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: “Invasive ...
Morningstar5d
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Further presentations covered the antifungal isavuconazole (Cresemba®) and the antibiotic ceftobiprole (Zevtera®). Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: “Invasive fungal ...
manilatimes5d
Basilea reports presentation of new data for fosmanogepix, isavuconazole (Cresemba®) and ceftobiprole (Zevtera®) at ESCMID Global 2025
Further presentations covered the antifungal isavuconazole (Cresemba ®) and the antibiotic ceftobiprole (Zevtera ®). Dr. Marc Engelhardt, Chief Medical Officer of Basilea, said: "Invasive fungal ...
Yahoo Finance4d
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
We have successfully launched two hospital brands, Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of bacterial infections. In addition, we have preclinical ...